Asian Spectator

The Times Real Estate

.

Jemincare initiates phase I clinical trial of anti-SARS-CoV-2 ...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
NANCHANG, China, Jan. 20, 2021 /Xinhua-AsiaNet/-- On January 15, Jemincare Group, a Chinese pharmaceutical company, announced that it has initiated the phase I clinical trial of anti-SARS-CoV-2 neutralizing antibody (JMB2002).Preclinical studies of JMB2002 including pharmacology and toxicity ...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

Expert Legal Help | Personal Injury Lawyer in Brisbane

Suffering a personal injury can be a traumatic and life-changing experience, leaving you wondering what to do next. Navigating the complex world of personal injury law in Brisbane can be overwhelmin...

#IndonesiaGelap: Alarm bagi publik agar tak terlena narasi penguasa

Mahasiswa dari berbagai kampus berpartisipasi dalam aksi Indonesia Gelap di Jakarta untuk memprotes kebijakan pemerintah.@jackjackparrrBermula dari media sosial, tagar #IndonesiaGelap menjadi bentuk a...

Ketika pemberitaan penuh tekanan, bagaimana cara tetap ‘update’ tanpa ‘doomscrolling’?

Mart Production/PexelsAwalnya sesederhana kita mengintip media sosial favorit di tengah malam sebelum tidur. Lalu muncullah judul-judul berita yang menarik perhatian dengan keterangan “breaking ...